John Christopher “J.C.” Rozendaal is a director and chair of Sterne Kessler’s Trial & Appellate Practice Group. J.C. focuses his practice on representing clients in complex business and intellectual property litigation, principally in federal court, and he regularly tries patent-infringement cases to juries. He frequently briefs and argues cases at the U.S. Court of Appeals for the Federal Circuit and has represented clients in the U.S. Supreme Court, both at the certiorari stage and on the merits.

J.C. has litigated patents on a wide variety of technologies, including pharmaceuticals, aseptic packaging systems, golf clubs, optical disc drives, medical ultrasound, Voice-over-Internet-Protocol, LCD flat-panel displays, and streaming video technology.

A growing part of J.C.’s practice includes counseling generic pharmaceutical companies on matters related to generic pharmaceuticals and biosimilars, as well as assisting international companies as they navigate the U.S. patent system. A seasoned litigator, J.C. is particularly adept at explaining complicated technical concepts to juries and judges who have no background in science or technology. Since 2019, he has been named an “IP Star” by Managing Intellectual Property. In 2021, J.C. became a Fellow of the American Bar Foundation, where membership is limited to just one percent of lawyers licensed to practice in each jurisdiction.

Prior to becoming a practicing attorney, J.C. served as a clerk for Judge Douglas H. Ginsburg, U.S. Court of Appeals, District of Columbia Circuit, and Justice Anthony M. Kennedy, U.S. Supreme Court.

J.C. earned his J.D. from the University of Texas School of Law, Austin, with highest honors. He received a B.A. and M.A. from Oxford University, Brasenose College, with first-class honors and a B.A. from the University of Texas, Austin, Plan II, with highest honors.

  • Allergan, Inc. v. Teva Pharmaceuticals USA, Inc. et al. (on behalf of Teva Pharmaceuticals, obtained district court judgment invalidating six patents protecting Restasis ophthalmic emulsion for treatment of dry eye; successfully defended judgment on appeal) (E.D. Tex. No. 2:15-cv-1455) (Fed. Cir. No. 2018-1130).
  • Steuben Foods, Inc. v. Shibuya Hoppmann Corp. et al. (currently representing Shibuya Hoppmann Corp. and other defendants in litigation involving aseptic bottling systems for low-acid foods) (W.D.N.Y) (1:10-cv-781).
  • MiiCs & Partners America, LLC et al. v. Funai Electric Co., Ltd.vet al. (on behalf of Funai Electric, obtained summary judgment of invalidity or non-infringement of five patents directed to LCD flat-panel televisions; successfully defended judgment on appeal) (D. Del. No. 1:14-cv-804) (Fed. Cir. No. 2018-1307).
  • In re Certain Audio Processing Hardware and Software and Products Containing the Same. (represented Dell Inc. in USITC investigation involving audio processing technology in first case to reach Commission in pilot program for rapid disposition of case-dispositive issues) (USITC 2015) (Inv. No. 337-TA-949).
  • Limelight Networks, Inc. v. Akamai Techs., Inc. (represented Limelight Networks in U.S. Supreme Court case involving Internet content delivery networks, resulting in 9-0 win and landmark ruling on divided infringement of method claims) (U.S. Supreme Court; 134 S.Ct. 2111 (2014)).
  • Wireless Ink Corp. v. Google, Inc. et al. (argued on behalf of Facebook and Google in Federal Circuit in case involving technology for managing Web sites designed to be accessed from mobile devices; successfully defended judgment of noninfringement) (Fed. Cir. 2014) (Nos. 2013-1683, 2013-1684).
  • Greenville Communications, L.L.C. v. Cellco Partnership d/b/a Verizon Wireless, (represented Verizon Wireless in obtaining favorable claim construction ruling and stipulated judgment of non-infringement in case involving wireless telephone calling features; successfully defended judgment on appeal) (D.N.J. 2012) (3:07-cv-4222) (Fed. Cir. 2013) (No. 2012-1676).
  • In re Gabapentin Patent Litigation (represented Teva Pharmaceuticals in jury trial of high-stakes patent infringement case involving drug for treatment of epilepsy; case settled on favorable terms two weeks into trial) (D.N.J. 2011) (MDL No. 1384).
  • Ricoh Co., Ltd. v. Quanta Computer, Inc. (successfully represented plaintiff Ricoh in obtaining reversal on appeal of unfavorable summary judgment ruling in patent infringement case brought against Taiwanese maker of optical disc drives; on remand, obtained $14.5 million jury verdict for patentee) (Fed. Cir. 2008) (550 F.3d 1325) (W.D. Wis. 2010) (No. 06-cv-462-bbc).

  • Best Lawyers, “The Best Lawyers in America®” (2024 – 2023)
  • LMG Life Sciences, “Hatch-Waxman Litigator of the Year – Generic” (2023)
  • IAM Patent 1000, “Washington, DC: Patent Litigation (Silver and Bronze Bands)” (2023 – 2018)
  • LMG Life Sciences, “Finalist – Hatch-Waxman Litigator of the Year – Generic” (2022, 2020)
  • World Intellectual Property Review (WIPR), “WIPR Leaders” (2023 – 2022)
  • Managing IP, “IP Star” (2023 – 2019)
  • LMG Life Sciences, “Life Sciences Star” (2023 – 2019)
  • LMG Life Sciences, “Hatch-Waxman Litigator of the Year” (2021)
  • Super Lawyers, “Super Lawyer – Washington, DC” (2024 – 2020)
  • Patexia, “100 Best Performing CAFC Attorneys Representing Appellees (Top 50)” (2022)

  • B.A., Oxford University, Brasenose College, with highest honors
  • B.A., Oxford University, Brasenose College, with first-class honors
  • B.A., Oxford University, Brasenose College, with highest honors

  • District of Columbia
  • Supreme Court of the United States
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Court of Appeals for the Fourth Circuit
  • U.S. Court of Appeals for the Ninth Circuit
  • U.S. District Court for the District of Columbia
  • Virginia

  • Federal Circuit Bar Association
  • American Bar Association
  • American Bar Foundation, Fellow

  • Supreme Court of the United States
  • U.S. Court of Appeals for the District of Columbia Circuit

  • French
  • German

Speaking Engagement

15th Summit on Biosimilars & Innovator Biologics

New York, NY, New York City Bar Association, June 20, 2024 11:30 AM - 12:30 PM EDT

Speaking Engagement

20th Paragraph IV Disputes Conference

New York, NY, April 25, 2024 10:30 AM - 11:30 AM EDT

Speaking Engagement

Preparing for Biosimilar Carve Outs: Will Skinny Labelling Work for Biosimilars?

Boston, MA, Metcalf Trustee Center, Boston University, June 27, 2023 4:15 PM - 5:15 PM EST

Speaking Engagement

The U.S. Patent Landscape

Virtual, September 15, 2020 11:35 AM - 12:35 PM EST

Speaking Engagement

2019 Global IP Strategy Conference

Washington, DC, March 15, 2019

Speaking Engagement

2018 Global IP Strategy Conference

Washington, DC, March 9, 2018 12:00 AM - 11:59 PM EST

Related News & Insights

From John Christopher "J.C." Rozendaal

Press Release

April 25, 2024

Eighteen Sterne Kessler Attorneys Recognized as 2024 “Super Lawyers” and “Rising Stars”

Sterne, Kessler, Goldstein & Fox

Firm Announcements

April 24, 2024

Sterne Kessler Secures Victory on Behalf of Teva Pharmaceuticals

Sterne, Kessler, Goldstein & Fox

In the News

April 23, 2024

US Supreme Court Denies Vanda's Bid to Revive Sleep Drug Patents

Life Sciences Intellectual Property Review

In the News

April 22, 2024

Supreme Court Won't Review Vanda's IP Obviousness Appeal

Law360

In the News

January 25, 2024

Petition Watch: Patent Obviousness, ADA Trials, Spoofing

Law360

In the News

January 4, 2024

Victory in the courtroom: Sweegen's Victory Redefines Stevia Sweetener

Korea IT Times

In the News

January 3, 2024

Teva Defeats Infringement Claims on Endocrine Drug

New Jersey Law Journal

Firm Announcements

January 3, 2024

Federal Circuit Affirms Sweet Win for SweeGen in Patent Invalidity Battle

Sterne, Kessler, Goldstein & Fox

Firm Announcements

January 3, 2024

Sterne Kessler Secures Non-Infringement Win for Teva Pharmaceuticals

Sterne, Kessler, Goldstein & Fox

In the News

January 2, 2024

Fed. Circ. Backs Calif. Decision Invalidating Sweetener IP

Law360

In the News

November 7, 2023

Fed. Circ. Judge Casts Doubt On Sweetener Enzyme Patents

Law360

Press Release

November 6, 2023

Sterne Kessler Notches Multiple Rankings in 2024 “Best Law Firms” List

Sterne, Kessler, Goldstein & Fox

Press Release

September 21, 2023

LMG Life Sciences Ranks Sterne Kessler and Seven Directors for Patent Litigation and Prosecution

Sterne, Kessler, Goldstein & Fox

Press Release

September 8, 2023

Sterne Kessler Presented With Two Top Honors at 2023 LMG Life Sciences Americas Awards

Sterne, Kessler, Goldstein & Fox

Firm Announcements

August 29, 2023

U.S. District Court Affirms Immigrant Children’s Constitutional Rights

Sterne, Kessler, Goldstein & Fox

In the News

July 25, 2023

Teva Exits Cancer Drug IP Row With 2031 Generic License

Law360

Press Release

July 6, 2023

Sterne Kessler and 14 Directors Earn Top Rankings in Managing IP’s 2023 “IP Stars” Guide

Sterne, Kessler, Goldstein & Fox

Press Release

July 6, 2023

Six Sterne Kessler Directors Distinguished by World Intellectual Property Review as 2023 WIPR Leaders

Sterne, Kessler, Goldstein & Fox

Press Release

April 24, 2023

Super Lawyers Recognizes 14 Sterne Kessler Attorneys as 2023 “Super Lawyers” and “Rising Stars”

Sterne, Kessler, Goldstein & Fox

In the News

March 15, 2023

Shibuya Sheds $38 Million Patent Loss With Noninfringement Order

Bloomberg Law

In the News

March 14, 2023

Fed. Circ. Unsure Vanda's Sleep Med Hetlioz Is Patentable

Law360

In the News

January 3, 2023

Fed. Circ. Won't Bar Generic Sleep Meds Amid Vanda Appeal

Law360

In the News

December 13, 2022

Teva, Apotex Win Ax of Patents in Sleep Drug Suit

Law360

In the News

December 1, 2022

Patexia Insight 161: Top CAFC Law Firms of 2022

Patexia

Press Release

September 22, 2022

Sterne Kessler and Seven Directors Recognized in LMG Life Sciences Rankings for the 10th Consecutive Year

Sterne, Kessler, Goldstein & Fox

In the News

September 12, 2022

Korean Co. Can't Be First To Invent CRISPR, PTAB Told

Law360

Press Release

September 9, 2022

Sterne Kessler Wins Hatch-Waxman Impact Case of the Year Award at 2022 LMG Life Sciences Americas Awards

Sterne, Kessler, Goldstein & Fox

Press Release

August 18, 2022

Seven Sterne Kessler Attorneys Recognized in 2023 Editions of Best Lawyers and Best Lawyers: Ones to Watch

Sterne, Kessler, Goldstein & Fox

Firm Announcements

August 8, 2022

Sterne Kessler Raises Over $34,000 for the Legal Aid Society of the District of Columbia

Sterne, Kessler, Goldstein & Fox

Press Release

June 2, 2022

Four Sterne Kessler Directors Named “WIPR Leaders” By World Intellectual Property Review

Sterne, Kessler, Goldstein & Fox

Firm Announcements

May 25, 2022

Sterne Kessler Team Secures Summary Judgment of Patent Invalidity on Behalf of Sweegen, Inc. in District Court

Sterne, Kessler, Goldstein & Fox

In the News

May 24, 2022

Stevia Patent Claims Fall After SweeGen Challenge

Law360

In the News

May 24, 2022

Sweegen Wins Challenges to Rival’s Artificial Sweetener Patents

Bloomberg Law

In the News

May 6, 2022

Fed. Circ. Rejects Narcan Maker's Redo Bid In Patent Suit

Law360

Press Release

May 1, 2022

Super Lawyers Recognizes 14 Attorneys as 2022 “Super Lawyers” and “Rising Stars”

Sterne, Kessler, Goldstein & Fox

In the News

March 31, 2022

EU Unified Patent Court Spurs Delight and Fear for Experts

Law360

In the News

February 18, 2022

Litigator of the Week Runners-Up and Shout Outs

Law.com

In the News

February 11, 2022

Federal Circuit Tosses Naloxone Patents

Law Street Media

In the News

February 10, 2022

Teva Win Invalidating Narcan Patents Upheld by Federal Circuit

Bloomberg Law

In the News

February 10, 2022

Court Affirms Teva Win in Fight Over Generic Narcan Anti-Overdose Drug

Reuters

In the News

February 10, 2022

Split Fed. Circ. Won't Restore 4 Narcan Patents

Law360

In the News

December 28, 2021

Tribunal Rule Among Top Patent Litigation Issues Going Into 2022

Bloomberg Law

Press Release

September 29, 2021

Sterne Kessler and Seven Directors Earn Top-Tier Designations in 2021 LMG Life Sciences Rankings

Sterne, Kessler, Goldstein & Fox

Press Release

September 23, 2021

Directors Ellison, Rozendaal, and Sterling Win Prominent LMG Life Sciences Americas Awards

Sterne, Kessler, Goldstein & Fox

In the News

September 7, 2021

AbbVie Settles Patent Dispute Over Muscle Stimulation Tech

Law360

In the News

August 2, 2021

Adapt Faces Tough Questions in Bid to Revive Narcan Patents

Bloomberg Law

In the News

July 29, 2021

IP Forecast: Fed. Circ. To Mull Narcan Patents

Law360

In the News

July 27, 2021

Teva to Defend Ruling Allowing Narcan Generic at Federal Circuit

Bloomberg Law

Client Alert

June 29, 2021

What You Should Know About the Supreme Court's Decision in Minerva

William H. Milliken

In the News

June 24, 2021

As Patent Pilot Program Ends, Judges Give Mixed Reviews

Law360

In the News

April 5, 2021

Justices Won't Revive Teva-IBSA Thyroid Drug Patent Fight

Law360

In the News

March 25, 2021

How 2020 ANDA Litigation Played Out – And What to Expect for 2021

Managing IP

In the News

January 3, 2021

Patent Litigation Trends To Watch In 2021

Law360

In the News

November 3, 2020

Justices Skip Case Horizon Said Puts 32K Patents At Risk

Law360

Press Release

October 8, 2020

Sterne Kessler Client Wins 2020 Nobel Prize in Chemistry for CRISPR-Cas9 Technology

Sterne, Kessler, Goldstein & Fox P.L.L.C.

In the News

October 8, 2020

Legal Industry News: Law Firm Hires, Recognition & Attorneys Getting Out the Vote

National Law Review

Press Release

October 6, 2020

Firm and Seven Directors Recognized in 2020 LMG Life Sciences Rankings

Sterne, Kessler, Goldstein & Fox P.L.L.C.

In the News

October 1, 2020

Teva Unit Tells High Court Not To Take Up Horizon's IP Loss

Law360

Press Release

September 24, 2020

Sterne, Kessler, Goldstein & Fox Wins Two 2020 LMG Life Sciences Americas Awards

Sterne, Kessler, Goldstein & Fox P.L.L.C.

In the News

July 31, 2020

Teva Gets Fed. Circ. to Affirm Thyroid Patent is Indefinite

Law360

In the News

June 23, 2020

Obviousness Doomed Narcan Patents After NJ Bench Trial

Law360

Press Release

June 16, 2020

Sterne, Kessler, Goldstein & Fox and 15 Directors Earn Top Rankings in IAM Patent 1000

Sterne, Kessler, Goldstein & Fox P.L.L.C.

In the News

June 5, 2020

Teva Invalidates Opiant Patents In Narcan Suit

Law360

Press Release

May 5, 2020

Sterne Kessler Ranked and 13 Directors Named “IP Stars” by Managing Intellectual Property

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Press Release

April 30, 2020

Sterne, Kessler, Goldstein & Fox Attorneys Named 2020 Super Lawyers and Rising Stars

Sterne, Kessler, Goldstein & Fox P.L.L.C.

Press Release

April 24, 2020

Sterne Kessler Again Receives Sole Band 1 Chambers Ranking for Patent Prosecution Among D.C. Firms

Sterne, Kessler, Goldstein & Fox P.L.L.C.

In the News

February 20, 2020

Rival Says Allergan Muscle Toner Not As Strong As Claimed

Law360

In the News

November 21, 2019

Teva Gets PTAB To Review Cushing's Syndrome Drug Patent

Law360

Bylined Articles

November 14, 2019

Fed. Circ.’s Arthrex Ruling: Unforeseen Consequences For IPR

Law360 Multiple Authors

In the News

September 30, 2019

PTAB Cuts Down Two More Allergan Restasis Patents

Law360

In the News

June 13, 2019

Fed. Circ. Expanded Patent Law's Reach, Enplas Tells Justices

Law360

Press Release

June 12, 2019

Sterne Kessler Prominent Again in Intellectual Asset Management Magazine’s "IAM Patent 1000"

Sterne, Kessler, Goldstein & Fox P.L.L.C

In the News

June 3, 2019

Supreme Court Refuses 'Blocking Patent' Rule Case

Law360

In the News

May 23, 2019

How Some IP Boutiques Are Thriving Amid Patent Law Shifts

Law360

Press Release

May 20, 2019

Sterne Kessler Tops Managing Intellectual Property’s IP Firm Rankings – Eleven Directors Named "IP Stars"

Sterne, Kessler, Goldstein & Fox P.L.L.C.

In the News

April 29, 2019

Law Firms: Legal Actions, Decisions

Bloomberg Law

In the News

April 26, 2019

Detained Children, Sponsors Get Cert. In Policy Challenge

Law360

In the News

April 8, 2019

Managing IP America Awards 2019 Winners Revealed

Managing Intellectual Property

In the News

April 6, 2019

Fed. Circ. Won't Revisit Restasis Patent Ruling

Law360

In the News

March 7, 2019

Justices Urged To Turn Down PTAB Tribal Immunity Case

Law360

In the News

March 6, 2019

Fed. Circ. Won't Revisit Restasis Patent Ruling

Law360

In the News

February 15, 2019

Restasis Patent Redo Bid 'Inappropriate,' Fed. Circ. Told

Law360

In the News

February 4, 2019

Golf Club Makers Settle Sprawling 23-Patent Suit

Law360

Press Release

January 22, 2019

Lawsuit Filed on Behalf of 10K Detained Children

In the News

January 22, 2019

Lawsuit Filed on Behalf of 10K Detained Children

In the News

January 22, 2019

Challenge To Immigrant Minors Detention Policy Expands

Law360

In the News

December 12, 2018

Fed. Circ. OKs Teva's Patent Win Over Allergan Colitis Drug

Law360

In the News

December 6, 2018

Fed. Circ. Questions Allergan On Water's Role In Colitis Patent

Law360

In the News

November 19, 2018

Fed. Circ. Erases Seoul Semiconductor's $4M Patent Award

Law360

In the News

November 16, 2018

Challenge to ORR Child Detention Policy

Legal Aid Justice Center

In the News

November 15, 2018

Challenge To Refugee Office Procedures Mostly Survives

Law360

In the News

November 13, 2018

Fed. Circ. Won't Restore Allergan's Restasis Patent Claims

Law360

In the News

November 6, 2018

Fed. Circ. Urged Not to Stay Immunity Ruling for Appeal

Law360

In the News

October 31, 2018

Allergan, Generic Cos. Battle Over Restasis Launch Plans

Law360

In the News

October 26, 2018

Allergan, Tribe Want IPRs Blocked As They Turn To High Court

Law360

In the News

October 22, 2018

Fed. Circ. Rejects Bid For PTAB Tribal Immunity Rehearing

Law360

In the News

September 19, 2018

No Need To Reconsider Immunity At PTAB, Fed. Circ. Hears

Law360

In the News

September 7, 2018

States Back Tribe, Allergan Fed. Circ. Bid For PTAB Immunity

Law360

In the News

August 29, 2018

Fed. Circ. Impeding Biopharma Innovation, Justices Told

Law360

In the News

August 20, 2018

Allergan, Tribe Want PTAB Immunity Denial Reheard En Banc

Law360

Firm Announcements

July 26, 2018

Sterne Kessler Prevails in the Release of Child from a Juvenile Detention Center

Sterne, Kessler, Goldstein & Fox

In the News

July 20, 2018

Fed. Circ. Says Tribal Immunity Doesn't Apply In IPR

Law360

Client Alert

June 29, 2018

WesternGeco v. Ion Geophysical

John Christopher “J.C.” Rozendaal

In the News

May 24, 2018

Hatch-Waxman Post-TC Heartland: What You Need To Know

Law360

In the News

March 26, 2018

Generic Cos. Tell Fed. Circ. Not To Halt PTAB Restasis IPRs

Law360

In the News

March 8, 2018

Don't Revive Restasis Patents, Generic Cos. Urge Fed. Circ.

Law360

In the News

January 1, 2018

Patent Litigation Trends To Watch In 2018

Law360

In the News

December 6, 2017

Analysing SCOTUS Oral Arguments in Oil States and SAS Institute

Managing Intellectual Property

In the News

December 5, 2017

Prison Phone Rivals Reach Confidential Deal in IP Row

Law360

Bylined Articles

August 25, 2017

Strategy Considerations for Biosimilar Applicants after Sandoz v. Amgen

Bloomberg BNA Multiple Authors

Bylined Articles

June 16, 2017

Supreme Court to Review Constitutionality of Inter Partes Review Process

Bloomberg BNA John Christopher “J.C.” Rozendaal, William H. Milliken

In the News

January 30, 2017

Sterne Kessler Adds 2 Kellogg Huber IP Pros as Directors

Law360

In the News

January 29, 2017

Washington-Area Appointments and Promotions for Jan. 30

The Washington Post

In the News

January 26, 2017

Sterne, Kessler, Goldstein & Fox Adds Directors

World Intellectual Property Review